Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
By Company (2025) 5.3
Who will come out on top
If treated as a generic, pharmacists will have more power to substitute prescriptions, accelerating uptake through price-based mechanisms, while if treated as a biosimilar, the decision on which brand is dispensed, under current common legislation, will typically lie with prescribers
FDA approved a new class of drugs for improving glucose control in adults with T2DM: sodium-glucose co-transporter 2 channel (SGLT-2) inhibitors (SGLT-2i) [94]
US$ 23.86
US$ 25.73
US$ 21.38
US$ 23.56
US$ 29.94
US$ 21.61
US$ 29.63
